• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童和青少年慢性髓性白血病的管理:来自儿童肿瘤学组 CML 工作组的建议。

Management of chronic myeloid leukemia in children and adolescents: Recommendations from the Children's Oncology Group CML Working Group.

机构信息

Division of Hematology/Oncology, McMaster Children's Hospital at Hamilton Health Sciences, Hamilton, Ontario, Canada.

Division of Hematology/Oncology, Ann and Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, Illinois.

出版信息

Pediatr Blood Cancer. 2019 Sep;66(9):e27827. doi: 10.1002/pbc.27827. Epub 2019 Jun 10.

DOI:10.1002/pbc.27827
PMID:31330093
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6944522/
Abstract

Chronic myeloid leukemia (CML) accounts for 2-3% of leukemias in children under 15 and 9% in adolescents aged 15-19. The diagnosis and management of CML in children, adolescents, and young adults have several differences compared to that in adults. This review outlines the diagnosis and management of the underlying disease as well as challenges that can occur when dealing with CML in this patient population.

摘要

儿童慢性髓性白血病(CML)占 15 岁以下儿童白血病的 2-3%,占 15-19 岁青少年白血病的 9%。儿童、青少年和年轻成人 CML 的诊断和管理与成人有许多不同。本文概述了基础疾病的诊断和管理,以及在该患者人群中治疗 CML 时可能出现的挑战。

相似文献

1
Management of chronic myeloid leukemia in children and adolescents: Recommendations from the Children's Oncology Group CML Working Group.儿童和青少年慢性髓性白血病的管理:来自儿童肿瘤学组 CML 工作组的建议。
Pediatr Blood Cancer. 2019 Sep;66(9):e27827. doi: 10.1002/pbc.27827. Epub 2019 Jun 10.
2
Management of Chronic Myeloid Leukemia in Children and Young Adults.儿童和青年慢性髓性白血病的治疗管理。
Curr Hematol Malig Rep. 2022 Oct;17(5):121-126. doi: 10.1007/s11899-022-00673-5. Epub 2022 Aug 3.
3
Chronic myeloid leukemia in children: clinical findings, management, and unanswered questions.儿童慢性髓系白血病:临床表现、治疗及未解决的问题。
Pediatr Clin North Am. 2015 Feb;62(1):107-19. doi: 10.1016/j.pcl.2014.09.008.
4
How I treat childhood CML.我是如何治疗儿童慢性髓性白血病的。
Blood. 2012 Feb 23;119(8):1821-30. doi: 10.1182/blood-2011-10-380774. Epub 2011 Dec 30.
5
Practice Patterns of Physician Treatment for Pediatric Chronic Myelogenous Leukemia.儿科慢性髓细胞白血病的医师治疗实践模式。
Biol Blood Marrow Transplant. 2019 Feb;25(2):321-327. doi: 10.1016/j.bbmt.2018.09.029. Epub 2018 Sep 26.
6
Diagnostic algorithms, monitoring, prognostication, and therapy in chronic myeloid leukemia (CML): a proposal of the Austrian CML platform.慢性髓性白血病(CML)的诊断算法、监测、预后和治疗:奥地利 CML 平台的建议。
Wien Klin Wochenschr. 2008;120(21-22):697-709. doi: 10.1007/s00508-008-1100-8.
7
Imatinib in the treatment of chronic myeloid leukemia in children and adolescents is effective and well tolerated: Report of the Polish Pediatric Study Group for the Treatment of Leukemias and Lymphomas.伊马替尼治疗儿童和青少年慢性粒细胞白血病疗效显著且耐受性良好:波兰儿童白血病和淋巴瘤治疗研究组报告
Adv Clin Exp Med. 2018 Jan;27(1):91-98. doi: 10.17219/acem/66462.
8
Pediatric chronic myeloid leukemia is a unique disease that requires a different approach.小儿慢性粒细胞白血病是一种需要采用不同治疗方法的独特疾病。
Blood. 2016 Jan 28;127(4):392-9. doi: 10.1182/blood-2015-06-648667. Epub 2015 Oct 28.
9
Long-term results of high-dose imatinib in children and adolescents with chronic myeloid leukaemia in chronic phase: the Italian experience.大剂量伊马替尼治疗儿童和青少年慢性期慢性髓性白血病的长期结果:意大利的经验。
Br J Haematol. 2015 Aug;170(3):398-407. doi: 10.1111/bjh.13453. Epub 2015 Apr 20.
10
Management of chronic myeloid leukemia in childhood.儿童慢性髓性白血病的治疗管理。
Curr Hematol Malig Rep. 2012 Jun;7(2):116-24. doi: 10.1007/s11899-012-0113-6.

引用本文的文献

1
Molecular characterization and antibiotic susceptibility of methicillin-resistant in immunocompromised cancer patients.免疫功能低下癌症患者中耐甲氧西林菌株的分子特征及抗生素敏感性
Int J Immunopathol Pharmacol. 2025 Jan-Dec;39:3946320251352258. doi: 10.1177/03946320251352258. Epub 2025 Aug 25.
2
[How I treat pediatric chronic myeloid leukemia].[我如何治疗小儿慢性粒细胞白血病]
Zhongguo Dang Dai Er Ke Za Zhi. 2025 Jul 15;27(7):792-801. doi: 10.7499/j.issn.1008-8830.2503021.
3
Rare manifestations of pediatric chronic myeloid leukemia: a case report on priapism and a literature Review.小儿慢性粒细胞白血病的罕见表现:一例阴茎异常勃起病例报告及文献综述
Front Oncol. 2025 Jun 19;15:1579981. doi: 10.3389/fonc.2025.1579981. eCollection 2025.
4
Global, regional, and national burden of leukemia, 1990-2021: a systematic analysis of the global burden of disease in 2021.1990 - 2021年全球、区域和国家白血病负担:2021年全球疾病负担的系统分析
Front Med (Lausanne). 2025 Apr 15;12:1542317. doi: 10.3389/fmed.2025.1542317. eCollection 2025.
5
Cases of Patients Treated in Countries With Limited Resources and Discussed by Experts of the International CML Foundation (iCMLf)-Case No. 2: Treatment-Free Remission After 9 Years of Imatinib Treatment Without Prior Achievement of Sustained Deep Molecular Response.国际慢性粒细胞白血病基金会(iCMLf)专家讨论的资源有限国家患者治疗案例 - 案例2:伊马替尼治疗9年后未预先实现持续深度分子反应的无治疗缓解
Case Rep Oncol Med. 2025 Mar 21;2025:3942816. doi: 10.1155/crom/3942816. eCollection 2025.
6
Therapeutic drug monitoring of imatinib in paediatric chronic myeloid leukaemia: Data from a real-world setting.伊马替尼在儿童慢性髓性白血病中的治疗药物监测:来自真实世界的数据。
Br J Haematol. 2025 May;206(5):1397-1405. doi: 10.1111/bjh.20047. Epub 2025 Mar 10.
7
Management of children and adolescents with chronic myeloid leukemia in chronic phase: International pediatric chronic myeloid leukemia expert panel recommendations.慢性期儿童和青少年慢性髓性白血病的管理:国际儿科慢性髓性白血病专家小组建议
Leukemia. 2025 Apr;39(4):779-791. doi: 10.1038/s41375-025-02543-4. Epub 2025 Mar 5.
8
Aiming Targeted Drug Development at Rare Pediatric Malignancies.针对罕见儿科恶性肿瘤的靶向药物开发。
J Clin Oncol. 2025 Apr;43(10):1173-1175. doi: 10.1200/JCO-25-00009. Epub 2025 Feb 3.
9
Cases of Patients Treated in Countries With Limited Resources and Discussed by Experts of the International CML Foundation (iCMLf)-Case No. 1: A Boy Presenting With Priapism and Loss of Vision.在资源有限国家接受治疗并经国际慢性粒细胞白血病基金会(iCMLf)专家讨论的患者病例 - 病例1:一名出现阴茎异常勃起和视力丧失的男孩。
Case Rep Oncol Med. 2024 Jul 29;2024:5534445. doi: 10.1155/2024/5534445. eCollection 2024.
10
BCR/ABL-Positive Chronic Myeloid Leukemia in Children: Current Treatment Approach.儿童 BCR/ABL 阳性慢性髓性白血病:当前治疗方法。
Curr Oncol Rep. 2024 Mar;26(3):250-257. doi: 10.1007/s11912-024-01502-z. Epub 2024 Feb 10.

本文引用的文献

1
Front-line imatinib treatment in children and adolescents with chronic myeloid leukemia: results from a phase III trial.一线伊马替尼治疗儿童和青少年慢性髓性白血病:III 期试验结果。
Leukemia. 2018 Jul;32(7):1657-1669. doi: 10.1038/s41375-018-0179-9. Epub 2018 Jun 20.
2
Frequent ASXL1 mutations in children and young adults with chronic myeloid leukemia.慢性髓性白血病儿童和青年中ASXL1突变频繁。
Leukemia. 2018 Sep;32(9):2046-2049. doi: 10.1038/s41375-018-0157-2. Epub 2018 Jun 13.
3
Dasatinib in Pediatric Patients With Chronic Myeloid Leukemia in Chronic Phase: Results From a Phase II Trial.达沙替尼治疗慢性期慢性髓性白血病儿科患者的疗效:来自 II 期试验的结果。
J Clin Oncol. 2018 May 1;36(13):1330-1338. doi: 10.1200/JCO.2017.75.9597. Epub 2018 Mar 2.
4
Pharmacology and pharmacokinetics of imatinib in pediatric patients.儿童患者伊马替尼的药理学和药代动力学。
Expert Rev Clin Pharmacol. 2018 Mar;11(3):219-231. doi: 10.1080/17512433.2018.1398644. Epub 2017 Nov 6.
5
Prognostic discrimination based on the EUTOS long-term survival score within the International Registry for Chronic Myeloid Leukemia in children and adolescents.基于儿童和青少年慢性髓性白血病国际登记处的 EUTOS 长期生存评分的预后判别。
Haematologica. 2017 Oct;102(10):1704-1708. doi: 10.3324/haematol.2017.170035. Epub 2017 Aug 24.
6
Practical Recommendations for Therapeutic Drug Monitoring of Kinase Inhibitors in Oncology.肿瘤学中激酶抑制剂治疗药物监测的实用建议
Clin Pharmacol Ther. 2017 Nov;102(5):765-776. doi: 10.1002/cpt.787. Epub 2017 Sep 7.
7
NCCN Guidelines Insights: Chronic Myeloid Leukemia, Version 1.2017.NCCN 指南解读:慢性髓性白血病,第 1.2017 版。
J Natl Compr Canc Netw. 2016 Dec;14(12):1505-1512. doi: 10.6004/jnccn.2016.0162.
8
Transition and transfer of childhood cancer survivors to adult care: A national survey of pediatric oncologists.儿童癌症幸存者向成人医疗护理的过渡与转诊:一项针对儿科肿瘤学家的全国性调查。
Pediatr Blood Cancer. 2017 Feb;64(2):346-352. doi: 10.1002/pbc.26156. Epub 2016 Jul 27.
9
Management of pregnant chronic myeloid leukemia patients.妊娠慢性髓系白血病患者的管理。
Expert Rev Hematol. 2016 Aug;9(8):781-91. doi: 10.1080/17474086.2016.1205479. Epub 2016 Jul 7.
10
Final 5-Year Study Results of DASISION: The Dasatinib Versus Imatinib Study in Treatment-Naïve Chronic Myeloid Leukemia Patients Trial.DASISION的5年最终研究结果:达沙替尼与伊马替尼治疗初治慢性髓性白血病患者的试验
J Clin Oncol. 2016 Jul 10;34(20):2333-40. doi: 10.1200/JCO.2015.64.8899. Epub 2016 May 23.